Search Results - "Rizvanova, A. S."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Atypical variants of chronic inflammatory demyelinating polyneuropathy with benign course: a clinical observation for 8 patients without pathogenic therapy by Grishina, D. A., Suponeva, N. A., Rizvanova, A. S.

    Published in Nervno-myshechnye bolezni (23-08-2020)
    “…Introduction . Atypical variants of chronic inflammatory demyelinating polyneuropathy are marked by its clinical heterogeneity and variable disease course. Aim…”
    Get full text
    Journal Article
  2. 2

    Clinical heterogeneity of chronic inflammatory demyelinating polyneuropathy: diagnostic challenges by Rizvanova, A. S., Grishina, D. A., Suponeva, N. A.

    Published in Alʹmanakh klinicheskoĭ medit͡s︡iny (17-03-2020)
    “…Сhronic inflammatory demyelinating polyneuropathy (CIDP) is the most prevalent acquired dysimmune neuropathy with clinical picture of symmetric motor and…”
    Get full text
    Journal Article
  3. 3

    Validation of a Russian version of the Berg Balance Scale by Suponeva, N. A., Yusupova, D. G., Zimin, A. A., Zaitsev, A. B., Yatsko, K. A., Melchenko, D. A., Rimkevichus, A. A., Zhirova, E. S., Taratukhina, A. S., Rizvanova, A. S., Gatina, G. A., Kalinkina, M. E., Piradov, M. A., Berg, K.

    “…Objective : linguistic and cultural adaptation of the original version of Berg Balance Scale (BBS) and assessment its psychometric properties. Patients and…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Стационарное течение атипичных форм хронической воспалительной демиелинизирующей полинейропатии: клиническое наблюдение за 8 пациентами без проведения патогенетической терапии by Гришина, Д А, Супонева, Н А, Ризванова, А С, Grishina, D A, Suponeva, N A, Rizvanova, A S

    Published in Nervno-myshechnye bolezni (01-01-2020)
    “…Введение. Атипичные формы хронической воспалительной демиелинизирующей полинейропатии отличаются клинической гетерогенностью и вариабельным течением. Цель…”
    Get full text
    Journal Article
  7. 7
  8. 8